See more : Redwood Trust, Inc. (RWT) Income Statement Analysis – Financial Results
Complete financial analysis of Daishin Chemical Co.,Ltd. (4629.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Daishin Chemical Co.,Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Capha Pharmaceuticals Inc. (FPSUF) Income Statement Analysis – Financial Results
- BGIL FILMS & TECHNOLOGIES LTD. (BGIL.BO) Income Statement Analysis – Financial Results
- CSL Limited (CMXHF) Income Statement Analysis – Financial Results
- Vesuvius plc (CKSNY) Income Statement Analysis – Financial Results
- North China Pharmaceutical Company Ltd. (600812.SS) Income Statement Analysis – Financial Results
Daishin Chemical Co.,Ltd. (4629.T)
About Daishin Chemical Co.,Ltd.
Daishin Chemical Co.,Ltd. manufactures and sells various paints and chemicals in Japan. The company's products include lacquer, melamine, acrylic resin, urethane resin, epoxy resin, paint thinners, and thinners for plastic; printing ink solvents, cleaning solvents, and industrial organic solvents; and paint removers, as well as ethanol and other products. It also offers reagents to support various tests, basic research, analysis, and environment, as well as product development, including pharmaceutical, textile, food, and electric products development. In addition, the company is involved in the sale of various materials ancillary to paint manufacturing; manufacture and sale of external substances and poisons for pharmaceutical industry; and related ancillary businesses. It sells its products to paint manufacturers, and printing ink and other industrial sectors through a network of sales agents. Daishin Chemical Co.,Ltd. was founded in 1952 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 32.46B | 34.39B | 31.30B | 25.65B | 28.06B |
| Cost of Revenue | 28.19B | 29.84B | 27.17B | 20.78B | 23.03B |
| Gross Profit | 4.27B | 4.55B | 4.13B | 4.86B | 5.03B |
| Gross Profit Ratio | 13.17% | 13.24% | 13.20% | 18.97% | 17.94% |
| Research & Development | 94.00M | 117.00M | 94.24M | 96.53M | 94.39M |
| General & Administrative | 1.55B | 1.66B | 1.86B | 1.79B | 0.00 |
| Selling & Marketing | 1.73B | 1.51B | 0.00 | 0.00 | 0.00 |
| SG&A | 3.28B | 1.66B | 1.86B | 1.79B | 3.40B |
| Other Expenses | 0.00 | 29.52M | 21.25M | 23.51M | 0.00 |
| Operating Expenses | 3.45B | 3.30B | 3.14B | 3.23B | 3.50B |
| Cost & Expenses | 31.64B | 33.14B | 30.31B | 24.02B | 26.53B |
| Interest Income | 340.00K | 521.00K | 738.00K | 734.00K | 413.00K |
| Interest Expense | 1.02M | 1.14M | 2.27M | 3.01M | 3.68M |
| Depreciation & Amortization | 407.25M | 367.04M | 379.43M | 363.98M | 323.37M |
| EBITDA | 1.34B | 1.68B | 1.41B | 2.04B | 1.93B |
| EBITDA Ratio | 4.14% | 4.86% | 4.51% | 7.93% | 6.63% |
| Operating Income | 825.74M | 1.25B | 993.70M | 1.63B | 1.54B |
| Operating Income Ratio | 2.54% | 3.65% | 3.17% | 6.36% | 5.48% |
| Total Other Income/Expenses | 110.85M | 55.85M | 37.66M | 42.47M | 68.86M |
| Income Before Tax | 936.59M | 1.31B | 1.03B | 1.67B | 1.61B |
| Income Before Tax Ratio | 2.89% | 3.81% | 3.29% | 6.52% | 5.73% |
| Income Tax Expense | 309.40M | 353.64M | 337.21M | 534.09M | 498.62M |
| Net Income | 627.19M | 955.95M | 694.14M | 1.14B | 1.11B |
| Net Income Ratio | 1.93% | 2.78% | 2.22% | 4.44% | 3.95% |
| EPS | 137.04 | 208.96 | 151.72 | 248.81 | 242.26 |
| EPS Diluted | 137.04 | 208.96 | 151.72 | 248.81 | 242.26 |
| Weighted Avg Shares Out | 4.58M | 4.57M | 4.58M | 4.58M | 4.58M |
| Weighted Avg Shares Out (Dil) | 4.58M | 4.57M | 4.58M | 4.58M | 4.58M |
Source: https://incomestatements.info
Category: Stock Reports